Upcoming Trials

Explore clinical trials expected to open for recruitment at PASO Medical.

  • HLX3902-FIH101
    A Phase Ia Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of HLX3902 (a STEAP1xCD3xCD28 Trispecific Antibody) in Patients with Metastatic Castration-Resistant Prostate Cancer and Other Advanced Solid Tumours
    Study Link

    HLX48-FIH101
    A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of HLX48 (EGFR/c-MET Bispecific Antibody-Drug Conjugate) in Participants with Advanced/Metastatic Solid Tumors
    Study Link

Click here to access a list of Current Trials